Retraction
MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro
Paper Information
Record ID:
43950
Publication Date:
January 01, 2019
Retraction Date:
April 19, 2023
(2.6 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
SAGE Publications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1177/15330338231154958Additional Notes:
see also: https://pubpeer.com/publications/9A56A5A1B43D233A79E2AD7E52E365?utm_source=Chrome%26utm_medium=BrowserExtension%26utm_campaign=Chrome
Citations (28)
28
Total Citations4
Post-Retraction(14.3%)
24
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
478
Days since retraction (latest)
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review
Ehsan Mehrtabar, Amirreza Khalaji, Mojtaba Pandeh et al. (9 authors)
Medical Oncology
Published: Aug 2024
3 citations
3 citations
478 days after retraction
The Impact of miR-122 on Cancer
Shijie Wu, Yiwen Wu, Sijun Deng et al. (5 authors)
Current Pharmaceutical Biotechnology
Published: Jan 2024
279 days after retraction
Chromosome 18
Sivasankari Ramadurai, Saurav Panicker, Satish Ramalingam
BENTHAM SCIENCE PUBLISHERS eBooks
Published: Aug 2023
119 days after retraction
The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver
Moaed E. Al‐Gazally, Ramsha Khan, Muhammad Imran et al. (12 authors)
International Immunopharmacology
Published: Jul 2023
8 citations
8 citations
101 days after retraction
Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphoma
Carlotta Caterina Damanti, Lavinia Ferrone, Enrico Gaffo et al. (21 authors)
Cancer Communications
Open Access
Published: Apr 2023
4 citations
4 citations
15 days before retraction
Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways
Siddesh Southekal, Sushil Kumar Shakyawar, Prachi Bajpai et al. (7 authors)
Cancers
Open Access
Published: Apr 2023
12 citations
12 citations
15 days before retraction
NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA
Chuanzhuo Wang, Xin He, Guangxin Yan et al. (4 authors)
Oncology Reports
Open Access
Published: Mar 2023
5 citations
5 citations
35 days before retraction
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
Mahboobeh Faramin Lashkarian, Nasrin Hashemipour, Negin Niaraki et al. (14 authors)
Cancer Cell International
Open Access
Published: Feb 2023
69 citations
69 citations
58 days before retraction
Prenatal arsenic exposure stymies gut butyrate production and enhances gut permeability in post natal life even in absence of arsenic deftly through miR122-Occludin pathway
Mainak Chakraborty, Anupam Gautam, Oishika Das et al. (5 authors)
Toxicology Letters
Open Access
Published: Dec 2022
3 citations
3 citations
135 days before retraction
RNA-Interference-Mediated miR-122-Based Gene Regulation in Colon Cancer, a Structural In Silico Analysis
Harsha Ganesan, Suman Kumar Nandy, Antara Banerjee et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2022
6 citations
6 citations
137 days before retraction
MiR-17-3p Facilitates Aggressive Cell Phenotypes in Colon Cancer by Targeting PLCD1 Through Affecting KIF14
Jinxing Ji, Jun Fu
Applied Biochemistry and Biotechnology
Published: Nov 2022
9 citations
9 citations
159 days before retraction
MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer
Jie Ding, Yifan Wen, Xu Yuan et al. (4 authors)
Genome Instability & Disease
Published: Aug 2022
3 citations
3 citations
236 days before retraction
Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity
Wanjia Tian, Junying Zhou, Mengyu Chen et al. (9 authors)
Scientific Reports
Open Access
Published: Jul 2022
23 citations
23 citations
285 days before retraction
Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC)
Lijuan Zhang, Xinyi Cai, Youguo Dai et al. (6 authors)
BioMed Research International
Open Access
Published: Jul 2022
2 citations
2 citations
287 days before retraction
Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
Yu Du, Zhuang Miao, Lijuan Qiu et al. (6 authors)
Journal of Healthcare Engineering
Open Access
Published: Jan 2022
8 citations
8 citations
463 days before retraction
Bioinformatics Analysis of Differential Gene and MicroRNA Expression in Lung Adenocarcinoma: Genetic Effects on Patient Prognosis, as Indicated by the TCGA Database
Bingqing Sun, Hongwen Zhao
Cancer Informatics
Open Access
Published: Jan 2022
1 citation
1 citation
473 days before retraction
Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer
Dipanwita Das, Nandini Karthik, Reshma Taneja
Sub-cellular biochemistry/Subcellular biochemistry
Published: Jan 2022
1 citation
1 citation
473 days before retraction
Long non-coding RNA AC122108.1 promotes lung adenocarcinoma brain metastasis and progression through the Wnt/β-catenin pathway by directly binding to aldolase A
Shaobin Feng, Huiling Liu, Peng Du et al. (6 authors)
Annals of Translational Medicine
Open Access
Published: Dec 2021
6 citations
6 citations
504 days before retraction
Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome
Karin Sanders, A.J.W. van Veldhuizen, H.S. Kooistra et al. (11 authors)
Frontiers in Veterinary Science
Open Access
Published: Nov 2021
9 citations
9 citations
518 days before retraction
miR-876-3p suppresses the progression of colon cancer and correlates the prognosis of patients
Huili Ma, Mintao Li, Zhuting Jia et al. (5 authors)
Experimental and Molecular Pathology
Published: Sep 2021
9 citations
9 citations
587 days before retraction
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Shamin Azwar, Heng Fong Seow, Maha Abdullah et al. (5 authors)
Biology
Open Access
Published: Aug 2021
123 citations
123 citations
596 days before retraction
Circulating microRNAs as noninvasive biomarkers for canine Cushing’s syndrome
Karin Sanders, A.J.W. van Veldhuizen, H.S. Kooistra et al. (11 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2021
610 days before retraction
Knockdown of miR-15b partially reverses the cisplatin resistance of NSCLC through the GSK-3β/MCL-1 pathway
Tianjian Lu, Wei-Ping Lu, Chunyi Jia et al. (5 authors)
Advances in Clinical and Experimental Medicine
Open Access
Published: Jul 2021
7 citations
7 citations
638 days before retraction
miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis
Da-Ye Yang, Dewei Zhang
Clinical and Experimental Medicine
Published: Apr 2021
8 citations
8 citations
739 days before retraction
Targeting the Metabolic Adaptation of Metastatic Cancer
Josep Tarragó‐Celada, Marta Cascante
Cancers
Open Access
Published: Apr 2021
15 citations
15 citations
748 days before retraction
Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion
Lei Sun, Xin Zhou, Qian Jiang et al. (5 authors)
Brazilian Journal of Medical and Biological Research
Open Access
Published: Jan 2021
5 citations
5 citations
838 days before retraction
MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi et al. (7 authors)
Life Sciences
Published: Jun 2020
30 citations
30 citations
1033 days before retraction
RETRACTED: Methyltransferase-like 1 (METTL1) served as a tumor suppressor in colon cancer by activating 7-methyguanosine (m7G) regulated let-7e miRNA/HMGA2 axis
Yang Liu, Yusheng Zhang, Qiang Chi et al. (5 authors)
Life Sciences
Open Access
Published: Mar 2020
55 citations
55 citations
1143 days before retraction
Quick Stats
Total Citations:
28
Years Since Retraction:
2.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025